Holen Sie sich die Stockscreener-App
1.67
4.37%
0.07
Handel nachbörslich:
1.65
-0.02
-1.20%
Schlusskurs vom Vortag:
$1.60
Offen:
$1.64
24-Stunden-Volumen:
348.67K
Relative Volume:
0.77
Marktkapitalisierung:
$218.19M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-35.47M
KGV:
-2.9298
EPS:
-0.57
Netto-Cashflow:
$-124.27M
1W Leistung:
-1.76%
1M Leistung:
-4.30%
6M Leistung:
-24.77%
1J Leistung:
+19.29%
1-Tages-Spanne:
$1.6178
$1.73
1-Wochen-Bereich:
$1.565
$1.82
52-Wochen-Spanne:
$1.18
$4.44
Prokidney Corp Stock (PROK) Company Profile
Firmenname
Prokidney Corp
Sektor
Branche
Telefon
336-999-7028
Adresse
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
Vergleichen Sie PROK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
1.67 | 218.19M | 0 | -35.47M | -124.27M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.40 | 113.67B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.08 | 74.97B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.68 | 40.50B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
277.16 | 35.95B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
120.88 | 29.63B | 3.30B | -501.07M | 1.03B | -2.1146 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-30 | Eingeleitet | JP Morgan | Neutral |
| 2024-09-10 | Eingeleitet | Guggenheim | Buy |
| 2024-03-07 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-01-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-07-25 | Eingeleitet | BTIG Research | Buy |
| 2022-12-21 | Eingeleitet | Jefferies | Buy |
| 2022-11-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-18 | Eingeleitet | UBS | Buy |
| 2022-10-14 | Eingeleitet | Citigroup | Buy |
| 2022-09-23 | Eingeleitet | BofA Securities | Buy |
| 2022-09-02 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Prokidney Corp Aktie (PROK) Neueste Nachrichten
US Penny Stocks: 3 Picks With Market Caps Under $300M - Simply Wall St
ProKidney secures out-of-market buyer, $20.5 million price tag for Greensboro site - The Business Journals
ProKidney's high-profile Greensboro plant initiative ends with planned $20 million sale of property - Winston-Salem Journal
ProKidney (NASDAQ:PROK) Trading 8.7% HigherStill a Buy? - MarketBeat
Insiders In ProKidney Still Down 26% On US$54.7m Investment - Simply Wall St
Barclays PLC Has $281,000 Position in ProKidney Corp. (NASDAQ:PROK) - Defense World
568,647 Shares in ProKidney Corp. (NASDAQ:PROK) Purchased by Hennion & Walsh Asset Management Inc. - MarketBeat
Jane Street Group LLC Has $78,000 Stock Holdings in ProKidney Corp. (NASDAQ:PROK) - Defense World
ProKidney Corp (PROK) Analyst Thoughts: How High Can It Go? - Stocks Register
ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
ProKidney to Present at J.P. Morgan Healthcare Conference, Spotlight on CKD Cell Therapy - StockTitan
Geode Capital Management LLC Grows Stock Position in ProKidney Corp. (NASDAQ:PROK) - Defense World
Geode Capital Management LLC Raises Stake in ProKidney Corp. (NASDAQ:PROK) - MarketBeat
Barclays PLC Purchases 124,667 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World
One ProKidney Insider Raised Their Stake In The Previous Year - Yahoo Finance
Stories to Watch in 2025: Will ProKidney change its Winston-Salem plans after abandoning $458M Greensboro facility? - The Business Journals
Cortexyme (NASDAQ:CRTX) vs. ProKidney (NASDAQ:PROK) Head to Head Comparison - Defense World
State Street Corp Has $2.74 Million Holdings in ProKidney Corp. (NASDAQ:PROK) - Defense World
ProKidney (NASDAQ:PROK) Shares Gap UpStill a Buy? - MarketBeat
TBJ's Top 24 of '24: ProKidney backs out of Guilford deal, invests in W-S facilities (No. 4) - Triad Business Journal
ProKidney (NASDAQ:PROK) Stock Price Down 2.5%Here's What Happened - MarketBeat
ProKidney (NASDAQ:PROK) Stock Price Up 6.2%Should You Buy? - MarketBeat
ProKidney (NASDAQ:PROK) Shares Down 4.8%Here's What Happened - MarketBeat
ProKidney Corp. (NASDAQ:PROK) Shares Bought by The Manufacturers Life Insurance Company - Defense World
Charles Schwab Investment Management Inc. Has $1.44 Million Holdings in ProKidney Corp. (NASDAQ:PROK) - MarketBeat
ProKidney (NASDAQ:PROK) Trading 5.9% HigherHere's What Happened - MarketBeat
Vigil Neuroscience (NASDAQ:VIGL) and ProKidney (NASDAQ:PROK) Head-To-Head Contrast - Defense World
JP Morgan Initiates Coverage of ProKidney (PROK) with Neutral Recommendation - MSN
ProKidney (NASDAQ:PROK) Trading 8.4% HigherWhat's Next? - MarketBeat
ProKidney (NASDAQ:PROK) Stock Price Up 5.4%Still a Buy? - MarketBeat
Suvretta Capital Management LLC Acquires 3,000,000 Shares of ProKidney Corp. (NASDAQ:PROK) - MarketBeat
ProKidney to Participate in Two Upcoming Conferences: - GlobeNewswire
ProKidney to Present at Evercore and Citi Healthcare Conferences in December | PROK Stock News - StockTitan
US Penny Stocks To Watch: 3 Picks With Market Caps Under $500M - Simply Wall St
The Best Laid Plans Of Mice And ProKidney… - The Rhino TImes
ProKidney purchases former Collins Aerospace facility, own HQ for $22.5M - The Business Journals
Future of development project promising hundreds of job now uncertain - MSN
ProKidney no longer coming to Greensboro, Chamber of Commerce confirms - MSN
ProKidney to buy two buildings in Winston-Salem. Announcement comes days after it listed Greensboro site for sale - Greensboro News & Record
ProKidney buys Winston-Salem land after passing on Greensboro deal - Business North Carolina
Finanzdaten der Prokidney Corp-Aktie (PROK)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.49%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):